TAFRO syndrome: 2 cases and review of the literature

References

• Masaki Y, Nakajima A, Iwao H, Kurose N, Sato T, Nakamura T, et al. Japanese variant of multicentric castleman's disease associated with serositis and thrombocytopenia–a report of two cases: is TAFRO syndrome (Castleman- Kojima disease) a distinct clinicopathological entity? J Clin Exp Hematop. 2013;53(1):79–85.
   PubMedGoogle Scholar
• Iwaki N, Sato Y, Takata K, Kondo E, Ohno K, Takeuchi M, et al. Atypical hyaline vascular-type castleman's disease with thrombocytopenia, anasarca, fever, and systemic lymphadenopathy. J Clin Exp Hematop. 2013;53(1):87–93.
   PubMedGoogle Scholar
• Ozawa T, Kosugi S, Kito M, Onishi M, Kida T, Nakata S, et al. Efficacy of rituximab for TAFRO syndrome, a variant type of multicentric Castleman's disease (in Japanese). Rinsho Ketsueki. 2014;55(3): 350–5.
   PubMedGoogle Scholar
• Kojima M, Nakamura N, Tsukamoto N, Otuski Y, Shimizu K, Itoh H, et al. Clinical implications of idiopathic multicentric castleman disease among Japanese: a report of 28 cases. Int J Surg Pathol. 2008;16(4):391–8.
   PubMed Web of Science ®Google Scholar
• Takai K, Nikkuni K, Shibuya H, Hashidate H. Thrombocytopenia with mild bone marrow fibrosis accompanied by fever, pleural effusion, ascites and hepatosplenomegaly (in Japanese). Rinsho Ketsueki. 2010;51(5):320–5.
   PubMedGoogle Scholar
• Kojima M, Nakamura N, Tsukamoto N, Yokohama A, Itoh H, Kobayashi S, et al. Multicentric Castleman's disease representing effusion at initial clinical presentation: clinicopathological study of seven cases. Lupus. 2011;20(1):44–50.
   PubMed Web of Science ®Google Scholar
• Kawabata H, Takai K, Kojima M, Nakamura N, Aoki S, Nakamura S, et al. Castleman-Kojima disease (TAFRO syndrome): a novel systemic inflammatory disease characterized by a constellation of symptoms, namely, thrombocytopenia, ascites (anasarca), microcytic anemia, myelofibrosis, renal dysfunction, and organomegaly: a status report and summary of Fukushima (6 June, 2012) and Nagoya meetings (22 September, 2012). J Clin Exp Hematop. 2013;53(1):57–61.
   PubMedGoogle Scholar
• Kubokawa I, Yachie A, Hayakawa A, Hirase S, Yamamoto N, Mori T, et al. The first report of adolescent TAFRO syndrome, a unique clinicopathologic variant of multicentric Castleman's disease. BMC Pediatr. 2014;14(1):139.
   PubMed Web of Science ®Google Scholar
• Suda T, Katano H, Delsol G, Kakiuchi C, Nakamura T, Shiota M, et al. HHV-8 infection status of AIDS-unrelated and AIDS-associated multicentric Castleman's disease. Pathol Int. 2001; 51(9):671–9.
   PubMed Web of Science ®Google Scholar
• Masaki Y. A novel variant of multicentric Castleman's disease associated with anasarca and thrombocytopenia;TAFRO syndrome (in Japanese). Ketsueki naika. 2014;68(1):97–102.
   Google Scholar
• Kawabata H, Kadowaki N, Nishikori M, Kitawaki T, Kondo T, Ishikawa T, et al. Clinical features and treatment of multicentric castleman's disease: a retrospective study of 21 Japanese patients at a single institute. J Clin Exp Hematop. 2013;53(1):69–77.
   PubMedGoogle Scholar
• Fajgenbaum DC, van Rhee F, Nabel CS. HHV-8-negative, idiopathic multicentric Castleman disease: novel insights into biology, pathogenesis, and therapy. Blood. 2014;123(19):2924–33.
   PubMed Web of Science ®Google Scholar
• Peterson BA, Frizzera G. Multicentric Castleman's disease. Semin Oncol. 1993;20(6):636–647.
   PubMed Web of Science ®Google Scholar
• Takai K, Nikkuni K, Momoi A, Nagai K, Igarashi N, Saeki T. Thrombocytopenia with reticulin fibrosis accompanied by fever, anasarca and hepatosplenomegaly: a clinical report of five cases. J Clin Exp Hematop. 2013;53(1):63–8.
   PubMedGoogle Scholar
• Togasaki E, Ohwada C, Kawajiri C, Shimizu R, Sugita Y, Yamazaki A, et al. Two cases of muticentric Castleman's disease initially presented with massive effusion and edema (in Japanese). Rinsho ketsueki. 2013;54(9):1447.
   Google Scholar
• Satoh T, Nakamura T, Nakajima A, Iwao H, Miki M, Sakai T, et al. A case of MCD associated with thrombocytopenia and anasarca, so-called TAFRO syndrome (in Japanese). Rinsho ketsueki. 2013;54(9):1447.
   Google Scholar
• Kawabata H, Kotani S, Matsumura Y, Kondo T, Katsurada T, Haga H, et al. Successful treatment of a patient with multicentric Castleman's disease who presented with thrombocytopenia, ascites, renal failure and myelofibrosis using tocilizumab, an anti-interleukin-6 receptor antibody. Intern Med. 2013;52(13):1503–7.
   PubMed Web of Science ®Google Scholar
• Tedesco S, Postacchini L, Manfredi L, Goteri G, Luchetti MM, Festa A, et al. Successful treatment of a Caucasian case of multifocal Castleman's disease with TAFRO syndrome with a pathophysiology targeted therapy - a case report. Exp Hematol Oncol. 2015;4(1):3.
   PubMedGoogle Scholar
• Inoue M, Ankou M, Hua J, Iwaki Y, Hagihara M, Ota Y. Complete resolution of TAFRO syndrome (thrombocytopenia, anasarca, fever, reticulin fibrosis and organomegaly) after immunosuppressive therapies using corticosteroids and cyclosporin A: a case report. J Clin Exp Hematop. 2013;53(1):95–9.
   PubMedGoogle Scholar
• Koduri PR, Parvez M, Kaza S, Pappu P, Anuradha S. Castleman-Kojima disease in a South Asian adolescent. J Clin Exp Hematop. 2014;54(2):163–6.
   PubMedGoogle Scholar
• Awano N, Inomata M, Sonoda Y, Kondoh K, Ono R, Moriya A, et al. A case of multicentric castleman's disease of mixed-type, which showed constellation of symptoms, i.e., thrombocytopenia, anasarca, anemia, fever, myelofibrosis, and lymphadenopathy. J Clin Exp Hematop. 2013;53(1):101–5.
   PubMedGoogle Scholar
• Pauwels P, Dal Cin P, Vlasveld LT, Aleva RM, van Erp WF, Jones D. A chromosomal abnormality in hyaline vascular Castleman's disease: evidence for clonal proliferation of dysplastic stromal cells. Am J Surg Pathol. 2000;24(6):882–8.
   PubMed Web of Science ®Google Scholar